Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs INCY✓SelectedUSD · INCYMRNA vs INCY performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs INCY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
INCY return
+77.5%
Excess return
-108.5%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioINCYExcessAlpha
1D-2.2%-1.1%-1.1%-1.3%
7D-12.7%-5.2%-7.5%-8.6%
30D-20.7%+1.0%-21.7%-21.4%
3M+46.3%-9.9%+56.2%+59.8%
6M+305.2%+18.1%+287.2%+271.0%
YTD+561.2%+16.1%+545.2%+508.2%
1Y+772.1%+12.6%+759.4%+717.7%
3Y+147.0%+109.5%+37.4%+32.7%
All-31.0%+77.5%-108.5%-63.6%

Cumulative growth

Daily Returns

Daily percentage return beside INCY.

Daily Out/Under-Performance

Portfolio return minus INCY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × INCY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded INCY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling